Livzon Pharmaceutical Group Inc. (SHE:000513)
China
· Delayed Price · Currency is CNY 36.39
+0.91 (2.56%)
Apr 1, 2025, 2:45 PM CST
SHE:000513 Revenue
In the year 2024, Livzon Pharmaceutical Group had annual revenue of 11.81B CNY, down -4.97%. Livzon Pharmaceutical Group had revenue of 2.73B in the quarter ending December 31, 2024, a decrease of -1.60%.
Revenue
11.81B
Revenue Growth
-4.97%
P/S Ratio
2.84
Revenue / Employee
1.30M
Employees
9,067
Market Cap
29.45B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 11.81B | -617.70M | -4.97% |
| Dec 31, 2023 | 12.43B | -199.54M | -1.58% |
| Dec 31, 2022 | 12.63B | 565.72M | 4.69% |
| Jan 1, 2022 | 12.06B | 1.54B | 14.67% |
| Jan 1, 2021 | 10.52B | 1.14B | 12.10% |
| Jan 1, 2020 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Jan 1, 2018 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Hengrui Medicine | 27.98B |
| Shenzhen Mindray Bio-Medical Electronics | 37.11B |
| WuXi AppTec | 37.92B |
| Aier Eye Hospital Group | 20.62B |
| Zhangzhou Pientzehuang Pharmaceutical., | 10.91B |
| Yunnan Baiyao Group Co.,Ltd | 40.03B |
| Shanghai United Imaging Healthcare | 10.30B |
| Sichuan Biokin Pharmaceutical | 5.82B |